Tenvie Therapeutics

Tenvie Therapeutics is a biotechnology company dedicated to engineering innovative small molecules that are transforming the treatment of neurological diseases. With a purpose-built foundation, Tenvie Therapeutics boasts a diverse portfolio of meticulously crafted small molecules, supported by a team of experienced CNS drug developers, poised to rapidly advance multiple clinical assets.

Tenvie Therapeutics is actively progressing a robust pipeline of therapeutics targeting neurological, cardiometabolic, and ophthalmic diseases. Their portfolio includes wholly owned, highly brain-penetrant, and precision-designed peripherally restricted small molecules, addressing three crucial drivers of disease: resolving inflammation, rescuing metabolic dysfunction, and restoring lysosomal function. The primary address of Tenvie Therapeutics is 161 Oyster Point Blvd, South San Francisco, California 94080, US.

Tenvie Therapeutics is committed to making a significant impact on patient care through groundbreaking research and development. Tenvie Therapeutics continuously strives to innovate and deliver novel therapeutic solutions for challenging medical conditions. We invite the management team at Tenvie Therapeutics to create a customized and exclusive company showcase and product listing on our platform to further highlight their achievements and capabilities.